Rocket Pharmaceuticals (RCKT) Debt to Equity (2014)
Rocket Pharmaceuticals' (RCKT) quarterly Debt to Equity came in at -$0.06 in Q4 2014.
Rocket Pharmaceuticals (RCKT) Debt to Equity (2014) Analysis & Trends
Rocket Pharmaceuticals has disclosed Debt to Equity across 1 years of filings, most recently posting -$0.06 for Q4 2014.
- Debt to Equity for Q4 2014 came in at -$0.06, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was -$0.06 (changed N/A YoY), and the FY2014 annual result was -$0.06, changed N/A from the prior year.
- Debt to Equity came in at -$0.06 for Q4 2014 at Rocket Pharmaceuticals.
- In the past five years, Debt to Equity ranged from a high of -$0.06 in Q4 2014 to a low of -$0.06 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -0.06 |